Correlation between systemic markers of inflammation and local synovitis in knee osteoarthritis by Babaei, Mansour et al.
Caspian J Intern Med 2019; 10(4):383-387  
DOI: 10.22088/cjim.10.4.383 
    Original Article 
 
 
 
 
 
Mansour Babaei (MD) 1, 2 
Yahya Javadian (PhD) 1, 2 
Hossein Narimani (MD) 3 
Mohammad Ranaei (MD) 2 
Behezad Heidari (MD) 1, 2 
Hossein Basereh (MD) 3 
Hemat Gholinia (MSc) 2 
Alireza Firouzjahi (MD) 2* 
 
 
 
1. Mobility Impairment Research 
Center, Health Research Institute, 
Babol University of Medical 
Sciences, Babol, Iran 
2. Clinical Research Development 
Unit of Rouhani Hospital, Babol 
University of Medical Sciences, 
Babol, Iran 
3. Student Research Committee, 
Babol University of Medical 
Sciences, Babol, Iran 
 
 
  
* Correspondence: 
Alireza Firouzjahi, Clinical 
Research Development Unit of 
Rouhani Hospital, Babol University 
of Medical Sciences, Babol, Iran 
 
 
E-mail: firouzal@hotmail.com 
Tel: 0098 1132138301 
Fax: 0098 1132238284 
 
 
 
 
 
 
 
 
 
 
 
 
 
Received: 5 Sep 2018  
Revised: 20 May 2019 
Accepted: 28 May 2019 
 
Correlation between systemic markers of inflammation 
and local synovitis in knee osteoarthritis 
 
Abstract 
Background: In the elderly population joint swelling, effusion and pain indicate local 
synovitis and the presence of inflammation. At present, no serum marker has been shown 
linking to knee synovitis in KOA. With regard to serum high sensitive C-reactive protein 
(hsCRP) as a measure of inflammation, this study aimed to determine the association of 
systemic inflammation with local synovitis, as well as with pain and muscle strength in 
KOA. 
Methods: The study population was selected consecutively among patients with KOA 
presented to Ayatollah Rouhani Hospital Rheumatology Clinic with knee joint synovitis. 
The diagnosis of KOA was confirmed according to the American College of 
Rheumatology diagnostic criteria. Data regarding radiographic, demographic and 
biochemical characteristics were provided and IL-17, IL-10, TGF-ß and hsCRP in serum 
and synovial fluid (SF) were measured in all patients. Stepwse linear regression models 
were used to determine the correlation between SF- hsCRP as a measure of local 
inflammation with other systemic or local markers of inflammation. 
Results: A total of 40 patients (women 65%) with mean age 65.6+8.9 (49-86) years, mean 
BMI 27.7+3.7 (22-38) kg/m2, were analyzed. SF-hsCRP was positively correlated with 
serum hsCRP as well as serum and SF cytokines. Knee pain was positively associated with 
BMI and radiographic severity and negatively with quadriceps muscle strength (QMS)  
(r=-0.350, p=0.029). In stepwise linear regression analysis the SF-hsCRP was positively 
correlated with serum hs-CRP (r=0.769, p=0.001), SF-IL-17 (r=0.428, p=0.001) and 
negatvely with serum IL-10 (r=-0.316, p=0.002). 
Conclusion: These findings indicate that systemic markers of inflammation such as serum 
hsCRP, and IL-17 are associated with local inflamation in KOA. 
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Knee osteoarthritis (KOA) is a chronic slowly progressive disease and one of the 
most frequent cause of mobility impairment and disability in the elderly population (1). 
Localized synovitis in KOA is associated with pain, swelling and cartilage break down. 
Release of synovial molecules and damaged cartilage from synovial inflammation leads to 
systemic inflammatory response and liberation of proinflammatory cytokines into the 
systemic circulation (2). Clinically, sudden increase in knee joint pain particularly at night, 
and morning stiffness reflect synovitis (3). In arthroscopic studies, localized thickening of 
synovium can be detected in 50 % of the patients with KOA (4). High sensitive serum  C-
reactive protein (hsCRP) as a measure of systemic inflammation has been detected in 
synovial fluid (SF) of patients with KOA and was associated with inflammation of 
synovium and knee pain (5-7). 
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Interleukin -17 ( IL-17) which plays an important role in 
the coordination of immune cells at early stage of 
inflammatory process in rheumatoid arthritis, has been also 
detected in sublining layer of the joint synovium in 
osteoarthritis (8). This cytokine contributes to the 
development of cartilage inflammation through stimulation 
of chondrocytes and synovial fibroblasts (3, 8). In one study, 
4 out of 152 patients with KOA (9.2%) had detctable IL-17 
in SF suggesting a potential for inflammatory phenotype (9). 
In other studies of patients with osteoarthritis, the serum 
level of IL-17 was significantly higher than healthy controls 
and was positively correlated with WOMAC pain (10-12). 
The IL-17 is involved in the early phase of the inflammatory 
process in KOA and upregulates the production of 
metalloproteinases and decreases the level of proteoglycan 
(8, 10), whereas other cytokines such as IL-10 and TGF-ß 
supress inflammation and reduce the rate of osteoarthritis 
progression (12-15). 
The diagnosis of KOA is based on clinical and 
radiographic features, and no appropriate laboratory marker 
has been identified to confirm the clinical diagnosis or 
display the presence of inflammatory process in 
osteoarthritis. Recognition of a serum marker to predict the 
presence of synovial inflammation in KOA would be helpful 
for both the diagnosis as well as for evaluation of treatment. 
Given hsCRP as a measure of inflammation, the aim of this 
study was to measure the level of hs-CRP in SF of patients 
with KOA and to determine its correlation with other 
systemic or local markers of inflammation. 
 
 
Methods 
The participants of this study were selected consecutively 
among patients with KOA presented to Ayatollah Rouhani 
Hospital Rheumatology Clinic, because of knee joint pain 
and swelling with effusion. The diagnosis of KOA was 
confirmed according to the American College of 
Rheumatology diagnostic criteria based on clinical as well as 
radiological criteria (16). Individuals aged ≥ 40 years with 
knee pain for at least one month or longer were included. 
Exclusion criteria consisted of coexistent local or systemic 
inflammatory processes, history of inflammatory 
arthropathies, knee joint surgery. All patients underwent 
radiographic examination and the severity of KOA was 
determined according to the Kellgren and Lawrence grading 
scores (K-L) between 0 indicating normal radiograph to 
grade 4 indicating severe joint space narrowing and 
osteophyte in tibifemoral joint. The intensity of knee pain 
was assessed by both visual analogue scales (VAS), where 0 
represented no pain and 100 mm indicated maximal knee 
pain, as well as by Western Ontario and McMaster 
University Osteoarthritis (WOMAC) pain scale consisted of 
5 items. Each component of the WOMAC index was scored 
by Likert scale from 0-4 (17). The presence of knee joint 
synovitis was confirmed by clinical examination and joint 
aspiration by exclusion of other causes of joint effusios. 
Serum and synovial fluid in all patients were aspirated and 
the number of white blood cell count, polynuclear cells in 
the synovial fluid were determined immidiately. The levels 
of serum and SF -hsCRP were measured by ELISA method. 
The proinflammatory cytokines levels in SF and serum were 
determined by ELISA method using kits purchased from the 
Crystal Day company, China. Additional data were collected 
regarding biochemical, serological and demographic 
characteristics. 
In statistical analysis, the association of SF-hsCRP as a 
measure of local inflammatory process was determined with 
serum hsCRP as well as with cytokines such as IL-17, IL 10, 
TGF-ß in the serum and SF. Stepwise linear regression 
models were used to determine correlation. Further analyses 
were applied to determine the association of pain with serum 
and SF-hsCRP, cytokines, radiographic severity, serum 
vitamin D and QMS. SSSP Version 22 were used for 
analysis. All patients gave informed consent and the 
proposal for this study was approved by the Ethics 
Committee of Babol University of Medical Sciences, Babol 
Iran. 
 
 
Results  
A total of 40 patients (women, 65%) with mean age 
65.6+8.9 (49-86) years, mean BMI 27.7+3.7 (22-38) kg/m2, 
were analyzed. Mean white blood cell count was 35+119 per 
ml SF. The levels of hs-CRP and cytokines in serum and SF 
are presented in table 1. As shown in table 1, the values of 
TGF-ß and IL-10 in SF were significantly higher than in 
serum, but the level of IL-17 in SF was nonsignificantly 
higher and the level of hsCRP was nonsignificantly lower in 
the SF as compared to serum. Radiographic evidence of 
grades 0-2 according to the K-L grading system was 
observed in 16 women and 11 men, and grades 3 and 4 were 
observed in 10 women and 3 men. The differences did not 
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reach to a statistical level .Knee pain in joint with synovitis 
was significantly higher than contralateral joint without 
synovitis (47.4+3.86 vs 13.2+2.89, p=0.001). The mean 
serum 25-hydroxyvitamin D was 37+18.5 ng/ ml, the ESR 
was 25+16 mm/h, the serum calcium was 9+0.38 mg/dl, the 
phosphate was 3.5+0.2 mg/dl the serum, uric acid was 
4.28+1.1 mg/dl. The mean serum hsCRP concentration in SF 
and serum was 2.31+1.59 and 2.60+2.03 mg/ml, respectively 
(p=0.34). The mean IL- 17 concentration in SF was 313+70 
(105-1182) pg/ml. The serum levels of proinflammatory 
cytokines in SF and serun are shown in table 1. 
 
Table 1. Serum and synovisl fluid levels of high sensitive 
serum C-reactive protein (hsCRP), and proinflammatory 
cytokines in patients with knee osteoarthritis and synovitis  
Variables  Synovial fluid 
Mean+SD (range) 
Serum 
Mean+SD 
p 
value 
Hs-CRP, 
mg/l 
2.52+1.59  
(0.92-8.95) 
2.91+2.04  
(1.09-10.1) 
0.34 
IL-17, pg/ml 313+70  
(105-1182) 
279+211 
(105-1182) 
0.33 
TGF-β, 
ng/ml 
2961.7+481  
(416-3230 
822+503 
(256-2601) 
0.001 
IL-10, pg/ml 427+153  
(129-697) 
280.1+145 
(166-800) 
0.001 
The results of correlative analysis between SF-hs-CRP 
and cytokines by linear regression analysis are shown in 
table 2. In stepwise linear regression analysis, the SF-hsCRP 
was positively correlated with serum hs-CRP (p=0.001) and 
SF-IL-17 (p=0.001) but negatively correlated with serum IL-
10 (p=0.002) (table 3). There was no correlation between 
knee pain and serum and synovial hs-CRP or cytokines. 
However, knee pain was positively associated with severity 
of radiographic abnormalities and BMI. 
 
Table 2. Correlation* between high sensitive C-reactive 
protein in synovial fluid (SF-hsCRP) and serum hsCRP 
as well as synovial and serum cytokines in patients with 
knee osteoarthritis and local synovitis.  
 
Serum Synovial fluid 
hsCRP IL-17 TGF-b IL-10 IL-17 TGF-b IL-10 
SF 
hsCRP 
0.795 0.464 0.394 -0.357 0.685 0.462 -0.474 
pvalues 0.001 0.003 0.012 0.024 0.001 0.003 0.024 
* Pearson correlation test was used 
Table 3. Stepwise linear regression analysis in relation to 
the association between synovial fluid (SF) high sensitive 
C-reactive protein (CRP), cytokines and body mass index 
(BMI). 
Variables 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
P 
value 
B Std. Error Beta 
Serum 
hsCRP 
0.606 0.083 0.769 0.000 
SF-IL17 0.010 0.002 0.428 0.000 
Serum-
IL10 
-0.003 0.001 -0.316 0.002 
 
 
Discussion 
These findings indicate that in patients with KOA, SF-hs-
CRP correlates positively with serum hs-CRP and SF-IL-17, 
and negatively with serum IL-10. A positive correlation 
between serum and SF- hs-CRP suggests a potential for 
serum hs-CRP in predicting local inflammatory process in 
KOA. Thus, in patients with localized synovitis, changes in 
severity of synovitis may be predicted by changes in serum 
hs-CRP concentration.  
The results of this study are consistent with the results of 
previous studies (5, 18, 19), and indicate that serum hs-CRP 
can be considered as a measure for detection of 
inflammatory state in KOA. Elevated level of SF- IL-17 and 
its positive correlation with inflammatory process suggests a 
pathophysiological role for this cytokine in the development 
of inflammatory process.  
In patients with rheumatoid arthritis, IL-17 cooridinates 
local inflammation and induces proinflammatory cytokines 
to perpetuate an inflammatory reaction, and contribute to the 
development of cartilage and synovial inflammation and 
bone destruction (8). Thus, production of IL-17 from 
synovial membrane of osteoarthritis joint may indicate a role 
for this cytokine in the initiation of synovitis in KOA (8). 
In a study by Snelling et al. high level of SF-hsCRP in 
KOA was suggestive of synovial inflammation as well as the 
presence of an ongoing inflammatory process (9).Chen et al. 
have shown an association between SF-IL-17 and 
radiographic severity in patients with KOA (20). In this 
study, the level of IL-10 in SF was significantly higher than 
in serum. This may be contributed to the release of synovial 
molecules and damaged cartilage from the inflammed 
synovium in response to systemic inflammation (13). IL-10 
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is an anti-inflammatory cytokine which regulates hemostasis 
of the immune system and slows progression of KOA (13). 
The negative correlation between SF-hs-CRP and serum IL-
10 indicate that increasing serum IL-10 is associsted with 
decreased SF-hs-CRP, which is consistent with the anti-
inflammatory and protective characteristics of IL-10 (21). A 
similar relationship has been reported in rheumatoid arthritis. 
Treatment of rheumatoid arthritis with methotrexate or gold 
salts is associated with increased level of serum IL-10 and 
decreased level of serum CRP (22, 23) 
In the present study, lack of correlation between pain and 
hs-CRP or cytokines may indicate contribution of factors 
other than synovitis to the development of pain in KOA (24, 
25). Limitations of this study include, absence of a control 
group for comparison of serum hsCRP or cytokines between 
KOA and healthy controls. The diagnosis of synovitis was 
made by clinical examination without histlogic examination. 
However, pain, swelling and aspiration of synovial fluid are 
highly suggestive of synovitis. The study design was cross-
sectional and so the observed association does not indicate 
causality. Detection of a significant correlation between 
serum and SF- hsCRP in this study should be considered as a 
strength, because data in this context are scarce. Nonetheless, 
lack of a control group prohibited to specify a cutoff level for 
serum hsCRP to discriminate patients with and without 
synovitis.  
In conclusion, the findings of this study indicate an 
association between systemic inflammatory process and 
local synovitus in patients with KOA. Thus, detection of an 
association between KOA and systemic inflammation would 
be possible by serum hs-CRP measurement. However,this 
issue requires further investigations. A longitudinal follow-
up study with measurements of serum and synovial hs-CRP 
at regular intervals, and detection of a significant correlation 
between changes in serum and SF hs-CRP concentrations 
might provide further documents for this purpose. 
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